Xolair has recently been approved for chronic idiopathic urticaria (CIU). The dose is 150 - 300 mg subcutaneously every 4 weeks. It runs ~ $900 for 150 mg and $1800 for 300 mg of Xolair (omalizumab) and is being aggressively marketed. This is a four page color flier that came with the August Archives of Dermatology. It is also being advertised on T.V.
Is she frowning because of her urticaria or because her insurance will not approve it?